Cedar Mountain Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EB
AAMU
JWM
P
SAM
OIAM
SFA
TFA
Cedar Mountain Advisors's DGX Position: Q2 2026 in Review
Cedar Mountain Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 33 shares worth $6.99K. The position accounts for ﹤0.01% of the portfolio, ranked #595.
Cedar Mountain Advisors first reported a position in DGX in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.3K in Q1 2025. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Cedar Mountain Advisors held 33 shares of Quest Diagnostics worth $6.99K as of Q2 2026.
- Cedar Mountain Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #595 holding.
- Cedar Mountain Advisors first reported a position in Quest Diagnostics in Q4 2019 and has held it in 27 quarters since.
- Cedar Mountain Advisors's Quest Diagnostics position peaked at $10.3K in Q1 2025.
- 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.